Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 439 entries
Sorted by: Best Match Show Resources per page
Informal education and developing entrepreneurial skills among farmers in Malaysia

informal education

Rezai G, Mohamed Z, Shamsudin MN.
GSID: MJoYRHRUlAkJ
G Rezai, Z Mohamed, MN Shamsudin - World Academy of Science …, 2011 - Citeseer

… through participating in informal entrepreneurship training or education. The outcome has shown us that the importance of informal training to … in the social background of farmers is necessary to understand their opinions on informal education for promoting...

Cite
Rezai, G., Mohamed, Z., & Shamsudin, M. N. (2011). Informal education and developing entrepreneurial skills among farmers in Malaysia. World Academy of Science, Engineering and Technology, 79, 254-261.
Rezai, Golnaz, Zainalabidin Mohamed, and Mad Nasir Shamsudin. "Informal education and developing entrepreneurial skills among farmers in Malaysia." World Academy of Science, Engineering and Technology 79 (2011): 254-261.
Copy Download .nbib Format: MLA
Infectious disease during hospitalization is the major causative factor for prolonged hospitalization: multivariate analysis of diagnosis procedure combination (DPC) data of 20,876 cases in Japan.

Journal of clinical biochemistry and nutrition

Fujii S, Hara M, Nonaka S, Ishikawa S, Aoki Y, Anzai K, Morita S, Fujimoto K, Mawatari M.
PMID: 27499579
J Clin Biochem Nutr. 2016 Jul;59(1):49-52. doi: 10.3164/jcbn.16-17. Epub 2016 Jul 01.

This study aimed to evaluate causative factors for prolonged hospitalization based on hospitalization status, type of hospital ward, and comorbidities, specifically diabetes mellitus and infectious diseases, in 20,876 patients hospitalized in Saga University Hospital from April 1, 2012, to...

Cite
Fujii S, Hara M, Nonaka S, et al. Infectious disease during hospitalization is the major causative factor for prolonged hospitalization: multivariate analysis of diagnosis procedure combination (DPC) data of 20,876 cases in Japan. J Clin Biochem Nutr. 2016;59(1):49-52doi: 10.3164/jcbn.16-17.
Fujii, S., Hara, M., Nonaka, S., Ishikawa, S., Aoki, Y., Anzai, K., Morita, S., Fujimoto, K., & Mawatari, M. (2016). Infectious disease during hospitalization is the major causative factor for prolonged hospitalization: multivariate analysis of diagnosis procedure combination (DPC) data of 20,876 cases in Japan. Journal of clinical biochemistry and nutrition, 59(1), 49-52. https://doi.org/10.3164/jcbn.16-17
Fujii, Susumu, et al. "Infectious disease during hospitalization is the major causative factor for prolonged hospitalization: multivariate analysis of diagnosis procedure combination (DPC) data of 20,876 cases in Japan." Journal of clinical biochemistry and nutrition vol. 59,1 (2016): 49-52. doi: https://doi.org/10.3164/jcbn.16-17
Fujii S, Hara M, Nonaka S, Ishikawa S, Aoki Y, Anzai K, Morita S, Fujimoto K, Mawatari M. Infectious disease during hospitalization is the major causative factor for prolonged hospitalization: multivariate analysis of diagnosis procedure combination (DPC) data of 20,876 cases in Japan. J Clin Biochem Nutr. 2016 Jul;59(1):49-52. doi: 10.3164/jcbn.16-17. Epub 2016 Jul 01. PMID: 27499579; PMCID: PMC4933693.
Copy Download .nbib Format: NLM
Can intravenous acetaminophen reduce the needs to more opioids to control pain in intubated patients?.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Mahshidfar B, Sameti A, Abbasi S, Farsi D, Mofidi M, Hafezimoghadam P, Rahimzadeh P, Rezai M.
PMID: 27630458
Indian J Crit Care Med. 2016 Aug;20(8):465-8. doi: 10.4103/0972-5229.188197.

AIMS: To evaluate the effect of intravenous (IV) acetaminophen on reducing the need for morphine sulfate in intubated patients admitted to the Intensive Care Unit (ICU).SETTINGS AND DESIGN: Current study was done as a clinical trial on the patients...

Cite
Mahshidfar B, Sameti A, Abbasi S, et al. Can intravenous acetaminophen reduce the needs to more opioids to control pain in intubated patients?. Indian J Crit Care Med. 2016;20(8):465-8doi: 10.4103/0972-5229.188197.
Mahshidfar, B., Sameti, A., Abbasi, S., Farsi, D., Mofidi, M., Hafezimoghadam, P., Rahimzadeh, P., & Rezai, M. (2016). Can intravenous acetaminophen reduce the needs to more opioids to control pain in intubated patients?. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 20(8), 465-8. https://doi.org/10.4103/0972-5229.188197
Mahshidfar, Babak, et al. "Can intravenous acetaminophen reduce the needs to more opioids to control pain in intubated patients?." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 20,8 (2016): 465-8. doi: https://doi.org/10.4103/0972-5229.188197
Mahshidfar B, Sameti A, Abbasi S, Farsi D, Mofidi M, Hafezimoghadam P, Rahimzadeh P, Rezai M. Can intravenous acetaminophen reduce the needs to more opioids to control pain in intubated patients?. Indian J Crit Care Med. 2016 Aug;20(8):465-8. doi: 10.4103/0972-5229.188197. PMID: 27630458; PMCID: PMC4994126.
Copy Download .nbib Format: NLM
Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging.

Journal of clinical biochemistry and nutrition

Ueno M, Matsumoto S, Matsumoto A, Manda S, Nakanishi I, Matsumoto KI, Mitchell JB, Krishna MC, Anzai K.
PMID: 28584395
J Clin Biochem Nutr. 2017 May;60(3):151-155. doi: 10.3164/jcbn.15-130. Epub 2017 Mar 25.

Effect of amifostine, a radiation-protecting drug, on muscle tissue partial pressure of oxygen was investigated by electron paramagnetic resonance spectroscopy and imaging. When amifostine was administered intraperitoneally or intravenously to mice, the linewidth of the electron paramagnetic resonance spectra...

Cite
Ueno M, Matsumoto S, Matsumoto A, et al. Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. J Clin Biochem Nutr. 2017;60(3):151-155doi: 10.3164/jcbn.15-130.
Ueno, M., Matsumoto, S., Matsumoto, A., Manda, S., Nakanishi, I., Matsumoto, K. I., Mitchell, J. B., Krishna, M. C., & Anzai, K. (2017). Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. Journal of clinical biochemistry and nutrition, 60(3), 151-155. https://doi.org/10.3164/jcbn.15-130
Ueno, Megumi, et al. "Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging." Journal of clinical biochemistry and nutrition vol. 60,3 (2017): 151-155. doi: https://doi.org/10.3164/jcbn.15-130
Ueno M, Matsumoto S, Matsumoto A, Manda S, Nakanishi I, Matsumoto KI, Mitchell JB, Krishna MC, Anzai K. Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. J Clin Biochem Nutr. 2017 May;60(3):151-155. doi: 10.3164/jcbn.15-130. Epub 2017 Mar 25. PMID: 28584395; PMCID: PMC5453015.
Copy Download .nbib Format: NLM
Characterization of microfluidic clamps for immobilizing and imaging of .

Biomicrofluidics

Ghaemi R, Rezai P, Nejad FR, Selvaganapathy PR.
PMID: 28580046
Biomicrofluidics. 2017 May 26;11(3):034113. doi: 10.1063/1.4984767. eCollection 2017 May.

No abstract available.

Cite
Ghaemi R, Rezai P, Nejad FR, et al. Characterization of microfluidic clamps for immobilizing and imaging of . Biomicrofluidics. 2017;11(3):034113doi: 10.1063/1.4984767.
Ghaemi, R., Rezai, P., Nejad, F. R., & Selvaganapathy, P. R. (2017). Characterization of microfluidic clamps for immobilizing and imaging of . Biomicrofluidics, 11(3), 034113. https://doi.org/10.1063/1.4984767
Ghaemi, Reza, et al. "Characterization of microfluidic clamps for immobilizing and imaging of ." Biomicrofluidics vol. 11,3 (2017): 034113. doi: https://doi.org/10.1063/1.4984767
Ghaemi R, Rezai P, Nejad FR, Selvaganapathy PR. Characterization of microfluidic clamps for immobilizing and imaging of . Biomicrofluidics. 2017 May 26;11(3):034113. doi: 10.1063/1.4984767. eCollection 2017 May. PMID: 28580046; PMCID: PMC5446281.
Copy Download .nbib Format: NLM
Clinical validation of genetic variants associated with .

Oncotarget

Fasching PA, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, Lux MP, Cunningham JM, Ruebner M, Jenkins G, Fridley B, Schneeweiss A, Tesch H, Lichtenegger W, Fehm T, Heinrich G, Rezai M, Beckmann MW, Janni W, Weinshilboum RM, Wang L.
PMID: 29100455
Oncotarget. 2017 May 09;8(44):78133-78143. doi: 10.18632/oncotarget.17726. eCollection 2017 Sep 29.

Hematotoxicity is one of the major side effects of chemotherapy. The aim of this study was to examine the association between single nucleotide polymorphisms (SNPs) and hematotoxicity in breast cancer patients in a subset of patients of the SUCCESS...

Cite
Fasching PA, Häberle L, Rack B, et al. Clinical validation of genetic variants associated with . Oncotarget. 2017;8(44):78133-78143doi: 10.18632/oncotarget.17726.
Fasching, P. A., Häberle, L., Rack, B., Li, L., Hein, A., Ekici, A. B., Reis, A., Lux, M. P., Cunningham, J. M., Ruebner, M., Jenkins, G., Fridley, B., Schneeweiss, A., Tesch, H., Lichtenegger, W., Fehm, T., Heinrich, G., Rezai, M., Beckmann, M. W., Janni, W., Weinshilboum, R. M., & Wang, L. (2017). Clinical validation of genetic variants associated with . Oncotarget, 8(44), 78133-78143. https://doi.org/10.18632/oncotarget.17726
Fasching, Peter A, et al. "Clinical validation of genetic variants associated with ." Oncotarget vol. 8,44 (2017): 78133-78143. doi: https://doi.org/10.18632/oncotarget.17726
Fasching PA, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, Lux MP, Cunningham JM, Ruebner M, Jenkins G, Fridley B, Schneeweiss A, Tesch H, Lichtenegger W, Fehm T, Heinrich G, Rezai M, Beckmann MW, Janni W, Weinshilboum RM, Wang L. Clinical validation of genetic variants associated with . Oncotarget. 2017 May 09;8(44):78133-78143. doi: 10.18632/oncotarget.17726. eCollection 2017 Sep 29. PMID: 29100455; PMCID: PMC5652844.
Copy Download .nbib Format: NLM
Uterine angioleiomyoma complicated by consumptive coagulopathy.

Gynecologic oncology case reports

Handler M, Rezai F, Fless KG, Litinski M, Yodice PC.
PMID: 24371629
Gynecol Oncol Case Rep. 2012 Apr 06;2(3):89-91. doi: 10.1016/j.gynor.2012.03.005. eCollection 2012.

► We present a rare case of consumptive coagulopathy secondary to a large degenerated uterine angioleiomyoma. ► Pathological examination showed features of angioleiomyoma, which are rarely found in the uterus. ► After removal of the neoplasm, the patient's consumptive...

Cite
Handler M, Rezai F, Fless KG, et al. Uterine angioleiomyoma complicated by consumptive coagulopathy. Gynecol Oncol Case Rep. 2012;2(3):89-91doi: 10.1016/j.gynor.2012.03.005.
Handler, M., Rezai, F., Fless, K. G., Litinski, M., & Yodice, P. C. (2012). Uterine angioleiomyoma complicated by consumptive coagulopathy. Gynecologic oncology case reports, 2(3), 89-91. https://doi.org/10.1016/j.gynor.2012.03.005
Handler, Marci, et al. "Uterine angioleiomyoma complicated by consumptive coagulopathy." Gynecologic oncology case reports vol. 2,3 (2012): 89-91. doi: https://doi.org/10.1016/j.gynor.2012.03.005
Handler M, Rezai F, Fless KG, Litinski M, Yodice PC. Uterine angioleiomyoma complicated by consumptive coagulopathy. Gynecol Oncol Case Rep. 2012 Apr 06;2(3):89-91. doi: 10.1016/j.gynor.2012.03.005. eCollection 2012. PMID: 24371629; PMCID: PMC3860903.
Copy Download .nbib Format: NLM
Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study.

Geburtshilfe und Frauenheilkunde

Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY.
PMID: 25568468
Geburtshilfe Frauenheilkd. 2014 Dec;74(12):1137-1143. doi: 10.1055/s-0034-1383401.

No abstract available.

Cite
Fasching PA, Fehm T, Kellner S, et al. Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe Frauenheilkd. 2014;74(12):1137-1143doi: 10.1055/s-0034-1383401.
Fasching, P. A., Fehm, T., Kellner, S., de Waal, J., Rezai, M., Baier, B., Baake, G., Kolberg, H. C., Guggenberger, M., Warm, M., Harbeck, N., Würstlein, R., Deuker, J. U., Dall, P., Richter, B., Wachsmann, G., Brucker, C., Siebers, J. W., Fersis, N., Kuhn, T., Wolf, C., Vollert, H. W., Breitbach, G. P., Janni, W., Landthaler, R., Kohls, A., Rezek, D., Noesslet, T., Fischer, G., Henschen, S., Praetz, T., Heyl, V., Kühn, T., Krauß, T., Thomssen, C., Kümmel, S., Hohn, A., Tesch, H., Mundhenke, C., Hein, A., Rauh, C., Bayer, C. M., Jacob, A., Schmidt, K., Belleville, E., Hadji, P., Wallwiener, D., Grischke, E. M., Beckmann, M. W., & Brucker, S. Y. (2014). Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe und Frauenheilkunde, 74(12), 1137-1143. https://doi.org/10.1055/s-0034-1383401
Fasching, P A, et al. "Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study." Geburtshilfe und Frauenheilkunde vol. 74,12 (2014): 1137-1143. doi: https://doi.org/10.1055/s-0034-1383401
Fasching PA, Fehm T, Kellner S, de Waal J, Rezai M, Baier B, Baake G, Kolberg HC, Guggenberger M, Warm M, Harbeck N, Würstlein R, Deuker JU, Dall P, Richter B, Wachsmann G, Brucker C, Siebers JW, Fersis N, Kuhn T, Wolf C, Vollert HW, Breitbach GP, Janni W, Landthaler R, Kohls A, Rezek D, Noesslet T, Fischer G, Henschen S, Praetz T, Heyl V, Kühn T, Krauß T, Thomssen C, Kümmel S, Hohn A, Tesch H, Mundhenke C, Hein A, Rauh C, Bayer CM, Jacob A, Schmidt K, Belleville E, Hadji P, Wallwiener D, Grischke EM, Beckmann MW, Brucker SY. Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study. Geburtshilfe Frauenheilkd. 2014 Dec;74(12):1137-1143. doi: 10.1055/s-0034-1383401. PMID: 25568468; PMCID: PMC4275317.
Copy Download .nbib Format: NLM
Cytotoxic effects of benzene metabolites on human sperm function: an in vitro study.

ISRN toxicology

Mandani P, Desai K, Highland H.
PMID: 24416599
ISRN Toxicol. 2013 Dec 12;2013:397524. doi: 10.1155/2013/397524. eCollection 2013.

In recent years, individuals are rampantly exposed to vapours of benzene, through paint, plastic, petroleum industries, fuel exhaust, and tobacco smoke. Hence the present investigation was directed towards determining the effect of benzene metabolites, namely, phenol-hydroquinone and catechol, on...

Cite
Mandani P, Desai K, Highland H. Cytotoxic effects of benzene metabolites on human sperm function: an in vitro study. ISRN Toxicol. 2013;2013:397524doi: 10.1155/2013/397524.
Mandani, P., Desai, K., & Highland, H. (2013). Cytotoxic effects of benzene metabolites on human sperm function: an in vitro study. ISRN toxicology, 2013397524. https://doi.org/10.1155/2013/397524
Mandani, Priyanka, et al. "Cytotoxic effects of benzene metabolites on human sperm function: an in vitro study." ISRN toxicology vol. 2013 (2013): 397524. doi: https://doi.org/10.1155/2013/397524
Mandani P, Desai K, Highland H. Cytotoxic effects of benzene metabolites on human sperm function: an in vitro study. ISRN Toxicol. 2013 Dec 12;2013:397524. doi: 10.1155/2013/397524. eCollection 2013. PMID: 24416599; PMCID: PMC3874944.
Copy Download .nbib Format: NLM
Modelling of aflatoxin G1 reduction by kefir grain using response surface methodology.

Journal of environmental health science & engineering

Ansari F, Khodaiyan F, Rezaei K, Rahmani A.
PMID: 26019874
J Environ Health Sci Eng. 2015 May 02;13:40. doi: 10.1186/s40201-015-0190-2. eCollection 2015.

Aflatoxin G1 (AFG1) is one of the main toxic contaminants in pistachio nuts and causes potential health hazards. Hence, AFG1 reduction is one of the main concerns in food safety. Kefir-grains contain symbiotic association of microorganisms well known for...

Cite
Ansari F, Khodaiyan F, Rezaei K, et al. Modelling of aflatoxin G1 reduction by kefir grain using response surface methodology. J Environ Health Sci Eng. 2015;13:40doi: 10.1186/s40201-015-0190-2.
Ansari, F., Khodaiyan, F., Rezaei, K., & Rahmani, A. (2015). Modelling of aflatoxin G1 reduction by kefir grain using response surface methodology. Journal of environmental health science & engineering, 1340. https://doi.org/10.1186/s40201-015-0190-2
Ansari, Farzaneh, et al. "Modelling of aflatoxin G1 reduction by kefir grain using response surface methodology." Journal of environmental health science & engineering vol. 13 (2015): 40. doi: https://doi.org/10.1186/s40201-015-0190-2
Ansari F, Khodaiyan F, Rezaei K, Rahmani A. Modelling of aflatoxin G1 reduction by kefir grain using response surface methodology. J Environ Health Sci Eng. 2015 May 02;13:40. doi: 10.1186/s40201-015-0190-2. eCollection 2015. PMID: 26019874; PMCID: PMC4445940.
Copy Download .nbib Format: NLM
Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom.

ClinicoEconomics and outcomes research : CEOR

Muthukumar M, Desai K, Abogunrin S, Harrower T, Gabriel S, Dinet J.
PMID: 28458568
Clinicoecon Outcomes Res. 2017 Apr 15;9:211-229. doi: 10.2147/CEOR.S112254. eCollection 2017.

BACKGROUND: Cervical dystonia (CD) involves painful involuntary contraction of the neck and shoulder muscles and abnormal posture in middle-aged adults. Botulinum neurotoxin type A (BoNT-A) is effective in treating CD but little is known about its associated cost-effectiveness.OBJECTIVE: To...

Cite
Muthukumar M, Desai K, Abogunrin S, et al. Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom. Clinicoecon Outcomes Res. 2017;9:211-229doi: 10.2147/CEOR.S112254.
Muthukumar, M., Desai, K., Abogunrin, S., Harrower, T., Gabriel, S., & Dinet, J. (2017). Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom. ClinicoEconomics and outcomes research : CEOR, 9211-229. https://doi.org/10.2147/CEOR.S112254
Muthukumar, Madhusubramanian, et al. "Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom." ClinicoEconomics and outcomes research : CEOR vol. 9 (2017): 211-229. doi: https://doi.org/10.2147/CEOR.S112254
Muthukumar M, Desai K, Abogunrin S, Harrower T, Gabriel S, Dinet J. Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom. Clinicoecon Outcomes Res. 2017 Apr 15;9:211-229. doi: 10.2147/CEOR.S112254. eCollection 2017. PMID: 28458568; PMCID: PMC5402907.
Copy Download .nbib Format: NLM
Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities.

Chronic obstructive pulmonary diseases (Miami, Fla.)

Mahler DA, Keininger DL, Mezzi K, Fogel R, Banerji D.
PMID: 28848901
Chronic Obstr Pulm Dis. 2016 Sep 09;3(4):758-768. doi: 10.15326/jcopdf.3.4.2016.0138.

No abstract available.

Cite
Mahler DA, Keininger DL, Mezzi K, et al. Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities. Chronic Obstr Pulm Dis. 2016;3(4):758-768doi: 10.15326/jcopdf.3.4.2016.0138.
Mahler, D. A., Keininger, D. L., Mezzi, K., Fogel, R., & Banerji, D. (2016). Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities. Chronic obstructive pulmonary diseases (Miami, Fla.), 3(4), 758-768. https://doi.org/10.15326/jcopdf.3.4.2016.0138
Mahler, Donald A, et al. "Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities." Chronic obstructive pulmonary diseases (Miami, Fla.) vol. 3,4 (2016): 758-768. doi: https://doi.org/10.15326/jcopdf.3.4.2016.0138
Mahler DA, Keininger DL, Mezzi K, Fogel R, Banerji D. Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities. Chronic Obstr Pulm Dis. 2016 Sep 09;3(4):758-768. doi: 10.15326/jcopdf.3.4.2016.0138. PMID: 28848901; PMCID: PMC5556959.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 439 entries